OSCR Stock Cash Flow Statements

Oscar Health Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

Oscar Health Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31

cash flows from operating activities:
net income	-228,491,000	275,506,000	-153,285,000	-54,388,000	56,312,000	177,482,000	-149,838,000	-65,703,000	-15,425,000	-39,628,000	-226,560,000	-193,547,000	-112,125,000	-77,320,000	-198,242,000	-212,745,000	-73,068,000	-87,371,000
adjustments to reconcile net income to net cash from operating activities:
deferred taxes		36,000	-2,270,000	-119,000	130,000	-79,000	-37,000	69,000	209,000	-183,000	-171,000	2,000			-109,000	-18,000	18,000	8,000
net realized gain on sale of financial instruments	-12,000	-119,000								43,000	5,000	761,000	-74,000	582,000	59,000	-20,000	-135,000	-113,000
depreciation and amortization expense	6,970,000	6,730,000	9,233,000	7,500,000	7,601,000	7,811,000	7,742,000	9,191,000	8,822,000	4,939,000	3,735,000	4,058,000	3,691,000	3,799,000	3,970,000	3,645,000	3,587,000	3,403,000
amortization of debt issuance costs	195,000	194,000	195,000	194,000	195,000	194,000	195,000	194,000	195,000	194,000	194,000	195,000	195,000	129,000	0	0	0	329,000
stock-based compensation expense	24,109,000	24,975,000	25,855,000	29,311,000	28,713,000	25,945,000	26,142,000	28,768,000	33,279,000	71,494,000	29,088,000	28,560,000	26,991,000	27,690,000	28,268,000	20,640,000	18,273,000	19,115,000
net accretion of investments	-7,994,000	-7,673,000		-6,737,000	-5,993,000	-6,226,000
change in benefit from credit losses	-15,300,000	-8,650,000	1,200,000	-300,000	-200,000	-1,000,000
changes in assets and liabilities:
(increase) / decrease in:
premium and other receivables	39,415,000	-164,225,000													-14,742,000	-31,904,000	-9,778,000	-10,529,000
risk adjustment transfer receivable	-491,000	-22,347,000	-1,267,000	8,624,000	-10,099,000	-10,112,000	2,202,000	6,209,000	-12,214,000	1,740,000	-5,605,000	10,262,000	-3,903,000	-9,956,000	2,439,000	-3,182,000	-2,151,000	-6,608,000
reinsurance recoverable	-5,151,000	103,990,000	-18,220,000	-32,034,000	1,652,000	-1,741,000	36,609,000	76,080,000	98,352,000	440,652,000	-68,409,000	-84,274,000	-154,516,000	-153,698,000
other assets	-13,247,000	-13,265,000	3,580,000	-2,126,000	-6,716,000	-6,285,000	7,453,000	2,560,000	5,820,000	-4,526,000	11,916,000	4,667,000	-16,083,000	-743,000	-4,169,000	538,000	588,000	-6,336,000
increase / (decrease) in:
benefits payable	86,054,000	108,848,000	4,000	104,498,000	3,881,000	282,361,000	55,536,000	54,738,000	-98,365,000	16,349,000	-58,032,000	115,233,000	119,198,000	247,747,000	16,257,000	90,002,000	49,256,000	46,152,000
unearned premiums	-1,408,000	-3,492,000	8,261,000	6,158,000	-5,571,000	-376,000	-5,684,000	-1,471,000	-277,000	-5,648,000	3,863,000	2,443,000	-2,009,000	-344,000	18,869,000	-7,707,000	-8,064,000	42,000
premium deficiency reserve			-1,444,000	-1,444,000	-1,444,000	-1,444,000	5,597,000	-3,203,000	-818,000	-14,000	-10,753,000	-6,539,000	-4,536,000	-3,205,000	-40,186,000	-4,675,000	-922,000	-9,542,000
accounts payable and other liabilities	-58,019,000	199,627,000	34,689,000	46,825,000	42,781,000	28,473,000	12,186,000	-3,036,000	-39,044,000	714,000	43,969,000	24,967,000	3,608,000	-14,733,000
reinsurance payable	-10,263,000	-17,703,000	-9,771,000	-8,977,000	-1,844,000	914,000	-6,291,000	-320,000	27,176,000	-387,191,000	-7,983,000	4,714,000	38,683,000	187,004,000	-16,079,000	-26,832,000	-11,913,000	-83,258,000
risk adjustment transfer payable	692,736,000	396,110,000	474,462,000	-695,159,000	443,016,000	279,081,000	305,745,000	-1,231,804,000	172,845,000	292,662,000	438,799,000	-419,638,000	332,273,000	371,661,000	181,168,000	-430,633,000	121,794,000	205,699,000
net cash from operating activities	509,067,000	878,542,000	346,820,000	-500,141,000	497,151,000	634,363,000	296,868,000	-1,149,266,000	165,524,000	414,715,000	151,394,000	-548,361,000	214,467,000	562,849,000	34,479,000	-589,252,000	55,337,000	317,691,000
capex	-9,277,000	-9,026,000	-6,819,000	-7,566,000	-7,562,000	-5,950,000	-6,102,000	-6,479,000	-5,617,000	-7,379,000	-7,130,000	-9,617,000	-6,018,000	-6,247,000	-7,206,000	-6,148,000	-5,948,000	-6,583,000
free cash flows	499,790,000	869,516,000	340,001,000	-507,707,000	489,589,000	628,413,000	290,766,000	-1,155,745,000	159,907,000	407,336,000	144,264,000	-557,978,000	208,449,000	556,602,000	27,273,000	-595,400,000	49,389,000	311,108,000
cash flows from investing activities:
purchase of investments	-270,969,000	-336,869,000	-110,461,000	-660,056,000	-806,300,000	-556,693,000	-214,799,000	-84,495,000	-335,038,000	-202,650,000	-849,528,000	-31,074,000	-145,335,000	-166,769,000	-284,168,000	-327,583,000
sale of investments	0	15,761,000	4,062,000				5,201,000	7,496,000	4,108,000	15,052,000	167,000	117,049,000	74,026,000	169,374,000	202,047,000	134,590,000	203,642,000	83,798,000
maturity and paydowns of investments	111,513,000	155,906,000
purchase of property, equipment and capitalized software	-9,277,000	-9,026,000	-6,819,000	-7,566,000	-7,562,000	-5,950,000	-6,102,000	-6,479,000	-5,617,000	-7,379,000	-7,130,000	-9,617,000	-6,018,000	-6,247,000	-7,206,000	-6,148,000	-5,948,000	-6,583,000
change in restricted deposits			-13,000	2,491,000	825,000	626,000	-2,377,000	622,000			-432,000	525,000	412,000	611,000	3,050,000
net cash from investing activities	-168,207,000	-174,228,000	-31,448,000	-577,770,000	-477,627,000	-300,589,000	172,477,000	225,303,000	43,898,000	135,509,000	-706,680,000	298,773,000	78,577,000	102,811,000	-19,837,000	-12,364,000	-708,034,000	-34,280,000
cash flows from financing activities:
tax payments related to net settlement of share-based awards	-1,434,000	-855,000
proceeds from exercise of stock options	23,567,000	5,728,000	3,817,000	18,560,000	18,702,000	27,309,000	1,070,000	300,000	2,551,000	35,000	5,000	370,000	364,000	560,000	5,743,000	11,201,000	2,988,000	29,652,000
net cash from financing activities	22,133,000	4,873,000	3,817,000	18,560,000	18,702,000	27,309,000	1,069,000	2,320,000	2,551,000	506,000	527,000	423,000	1,385,000	298,775,000	12,973,000	11,201,000	2,988,000	1,211,550,000
increase in cash, cash equivalents and restricted cash equivalents	362,993,000	709,187,000			38,226,000	361,083,000	470,414,000	-921,643,000	211,973,000	550,730,000	-554,759,000	-249,165,000	294,429,000	964,435,000	27,615,000	-590,415,000	-649,709,000	1,494,961,000
cash, cash equivalents, restricted cash and cash equivalents—beginning of period	0	1,551,118,000	0	0	0	1,891,971,000	0	0	0	1,580,497,000	0	0	0	1,125,557,000	0	0	0	843,105,000
cash, cash equivalents, restricted cash and cash equivalents—end of period	362,993,000	2,260,305,000	319,189,000	-1,059,351,000	38,226,000	2,253,054,000	470,414,000	-921,643,000	211,973,000	2,131,227,000	-554,759,000	-249,165,000	294,429,000	2,089,992,000	27,615,000	-590,415,000	-649,709,000	2,338,066,000
cash and cash equivalents	362,387,000	2,236,555,000	321,041,000	-1,062,009,000	37,355,000	2,230,799,000	470,524,000	-922,278,000	212,498,000	2,109,571,000	-554,335,000	-249,702,000	294,000,000	2,068,632,000	27,296,000	-594,841,000	-649,747,000	2,321,287,000
restricted cash and cash equivalents included in restricted deposits	606,000	23,750,000	-1,852,000	2,658,000	871,000	22,255,000	-110,000	635,000	-525,000	21,656,000	-424,000	537,000	429,000	21,360,000	319,000	4,426,000	38,000	16,779,000
total cash, cash equivalents and restricted cash and cash equivalents	362,993,000	2,260,305,000	319,189,000	-1,059,351,000	38,226,000	2,253,054,000	470,414,000	-921,643,000	211,973,000	2,131,227,000	-554,759,000	-249,165,000	294,429,000	2,089,992,000	27,615,000	-590,415,000	-649,709,000	2,338,066,000
supplemental disclosures:
interest payments	11,206,000	154,000	11,211,000	11,211,000	151,000	11,118,000
income tax payments			38,000	552,000
investment amortization (accretion), net of accretion
maturity of investments			81,783,000	66,173,000	335,410,000	261,428,000	390,554,000	308,159,000	380,967,000	330,486,000	150,243,000	221,890,000	155,492,000	105,842,000	66,440,000	183,152,000	46,903,000	134,199,000
proceeds from long-term debt											0	0	0	305,000,000
payments of debt issuance costs											0	0	0	-7,035,000
proceeds from joint venture contribution							-1,000	2,020,000	0	471,000	522,000	53,000	1,021,000	250,000
net realized loss on sale of financial instruments								61,000
premiums and accounts receivable				98,031,000	-55,263,000	-140,635,000	-22,783,000	-14,018,000	-7,044,000	30,440,000		-41,222,000	-16,951,000	-18,884,000
decrease in cash, cash equivalents and restricted cash equivalents
loss on fair value of warrant liabilities
net amortization (accretion) of investments							-6,518,000
debt extinguishment loss															0	0	0	20,178,000
benefit from credit losses
debt prepayment															0	0	0	-153,173,000
debt extinguishment costs															0	0	0	-12,994,000
proceeds from ipo, net of underwriting discounts															0	0	0	1,348,321,000
offering costs from ipo															0	0	0	-9,447,000
proceeds from exercise of warrants and call options															0	0	0	9,191,000
proceeds from partial sale of subsidiary to noncontrolling interest
investment amortization, net of accretion									-7,953,000	-7,322,000	-1,658,000	997,000	1,219,000	1,922,000	2,541,000	2,461,000	1,955,000	1,074,000
convertible preferred stock and call option issuances
(gain) loss on fair value of warrant liabilities																		12,856,000
accrued investment income														1,198,000	-696,000	708,000	-2,349,000	417,000
balances due from reinsurance programs															-18,201,000	-13,615,000	-46,178,000	225,397,000
accounts payable and accrued liabilities															73,332,000	24,085,000	14,424,000	-13,222,000
other
stock repurchased
purchase of fixed maturity securities																		-245,694,000

We provide you with 20 years of cash flow statements for Oscar Health stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Oscar Health stock. Explore the full financial landscape of Oscar Health stock with our expertly curated income statements.

The information provided in this report about Oscar Health stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.